179 related articles for article (PubMed ID: 24558934)
1. [Subtypes of acute ischemic stroke and neurological prognosis].
Erabi Y; Kouhisa Y; Murakami S; Okada Y; Hidaka S; Nakagawa I
Masui; 2014 Jan; 63(1):68-73. PubMed ID: 24558934
[TBL] [Abstract][Full Text] [Related]
2. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
[TBL] [Abstract][Full Text] [Related]
3. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy].
Idei M; Sasaki T; Tanabe T; Muraoka K; Terada K; Meguro T; Hirotsune N; Nishino S
No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535
[TBL] [Abstract][Full Text] [Related]
4. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
[TBL] [Abstract][Full Text] [Related]
5. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
[TBL] [Abstract][Full Text] [Related]
6. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
7. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era.
Endo K; Koga M; Sakai N; Yamagami H; Furui E; Matsumoto Y; Shiokawa Y; Yoshimura S; Okada Y; Nakagawara J; Hyogo T; Hasegawa Y; Nagashima H; Fujinaka T; Hyodo A; Terada T; Toyoda K;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823
[TBL] [Abstract][Full Text] [Related]
8. NIHSS-time score easily predicts outcomes in rt-PA patients: the SAMURAI rt-PA registry.
Aoki J; Kimura K; Koga M; Kario K; Nakagawara J; Furui E; Shiokawa Y; Hasegawa Y; Okuda S; Yamagami H; Okada Y; Shibazaki K; Sakamoto Y; Toyoda K
J Neurol Sci; 2013 Apr; 327(1-2):6-11. PubMed ID: 23433814
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes after intravenous fibrinolysis in cryptogenic strokes with or without patent foramen ovale.
Chang JJ; Chiem T; Alderazi YJ; Chapple K; Restrepo L
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e492-9. PubMed ID: 23871701
[TBL] [Abstract][Full Text] [Related]
10. Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke scale score during 1-h recombinant tissue-type plasminogen activator infusion.
Osaki M; Miyashita F; Koga M; Fukuda M; Shigehatake Y; Nagatsuka K; Minematsu K; Toyoda K
Eur J Neurol; 2014 Mar; 21(3):411-8. PubMed ID: 24200315
[TBL] [Abstract][Full Text] [Related]
11. [Prospects of thrombolytic therapy for acute ischemic stroke].
Nakashima T; Minematsu K
Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
[TBL] [Abstract][Full Text] [Related]
12. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
[TBL] [Abstract][Full Text] [Related]
13. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D
Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482
[TBL] [Abstract][Full Text] [Related]
14. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India.
Boddu DB; Srinivasarao Bandaru VC; Reddy PG; Madhusudan M; Rukmini MK; Suryaprabha T; Jabeen SA; Suvarna A; Jayalakshmi SS; Meena AK; Borgohain R; Kaul S
Neurol India; 2010; 58(3):403-6. PubMed ID: 20644268
[TBL] [Abstract][Full Text] [Related]
15. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
[TBL] [Abstract][Full Text] [Related]
16. Benefits of intravenous thrombolysis in acute ischemic stroke related to extra cranial internal carotid dissection. Dream or reality?
Fuentes B; Masjuan J; Alonso de Leciñana M; Simal P; Egido J; Díaz-Otero F; Gil-Nuñez A; Martínez-Sánchez P; Díez-Tejedor E;
Int J Stroke; 2012 Jan; 7(1):7-13. PubMed ID: 22017881
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous thrombolysis patients with acute ischemic stroke: the analysis of the 100 cases. Part I. Characteristic of the patients and effectiveness of treatment].
Sobolewski P; Sledzińska M; Szczuchniak W; Hatalska-Zerebiec R; Grzesik M; Sobota A
Przegl Lek; 2012; 69(6):237-41. PubMed ID: 23094435
[TBL] [Abstract][Full Text] [Related]
18. Very mild stroke patients benefit from intravenous tissue plasminogen activator without increase of intracranial hemorrhage.
Hassan AE; Hassanzadeh B; Tohidi V; Kirmani JF
South Med J; 2010 May; 103(5):398-402. PubMed ID: 20375952
[TBL] [Abstract][Full Text] [Related]
19. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report.
Matsuzaki T; Yoshino A; Sakatani K; Katayama Y
J Stroke Cerebrovasc Dis; 2011; 20(3):269-72. PubMed ID: 20630773
[TBL] [Abstract][Full Text] [Related]
20. Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.
Deguchi I; Takeda H; Furuya D; Dembo T; Nagoya H; Kato Y; Ito Y; Fukuoka T; Maruyama H; Tanahashi N
J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):108-13. PubMed ID: 20851627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
